Approval · Notice of Compliance 13440 · 2012
ALVESCO: Notice of Compliance 13440
Issued June 27, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13440
- Date
- June 27, 2012
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Corticosteroid for Oral Inhalation
Products in this notice
Medicinal ingredients
- CICLESONIDE 50 MCG per ACT
- CICLESONIDE 100 MCG per ACT
- CICLESONIDE 200 MCG per ACT